首頁 > 市場調查報告書 > 製藥

消化器

市場調查報告書

商品編碼

1378865

胃腸道治療市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Gastrointestinal Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: 2023年11月02日 | 出版商:

IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

概要

2022年全球胃腸道治療市場規模達到442億美元。展望未來， IMARC Group預計到2028年市場規模將達到596億美元，2022-2028年複合年成長率（CAGR）為5.1%。

胃腸道 (GI) 症候群是指影響消化道器官功能的醫學疾病。它會影響胃、胰臟、小腸和大腸、膽囊和肝臟，通常表現為消化不良、胃灼熱、便秘和腹脹。一些常用的胃腸道治療方法包括處方藥和非處方藥 (OTC)，例如制酸劑、瀉藥、止瀉劑、止吐劑、抗潰瘍劑以及內視鏡和放射學檢查以及血液學檢查。這些療法有助於檢測疾病並吸收食物中的營養物質以改善消化，調節胃腸道系統中的水流量並最大限度地減少胃酸。

發炎性腸道疾病（IBD）和潰瘍性結腸炎等胃腸道疾病的盛行率不斷上升，是推動市場成長的關鍵因素之一。由於生活方式的改變和不健康的飲食習慣，全球患者疾病復發的可能性增加。此外，老年人口的增加也推動了市場的成長，老年人口更容易罹患此類疾病。各種技術進步，例如用於治療該疾病的創新生物相似藥和細胞療法的開發，正在充當其他生長誘導因素。這些生物製劑透過靜脈內和皮下注射進行給藥，並針對針對性治療進行個人化。其他因素，包括大眾健康意識的提高、廣泛的研發（R＆D）活動以及醫療基礎設施的顯著改善（尤其是在發展中經濟體），預計將進一步推動市場發展。

本報告回答的關鍵問題：

迄今為止，全球胃腸道治療市場表現如何，未來幾年將如何表現？
COVID-19 對全球胃腸道治療市場有何影響？
主要區域市場有哪些？
依類型分類市場是怎麼樣的？
根據給藥途徑，市場的分化為何？
基於應用程式的市場區隔是什麼？
基於配銷通路的市場區隔是什麼？
產業價值鏈的各個階段是什麼？
該行業的關鍵促進因素和挑戰是什麼？
全球胃腸道治療市場的結構如何？誰是主要參與者？
產業競爭程度如何？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 按國家/地區分類的市場細分
- 市場預測

第 11 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 14 章：價格分析

第15章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Abbott Laboratories
- AbbVie Inc.
- AstraZeneca Plc
- Bausch Health Companies Inc.
- Bayer Aktiengesellschaft
- GlaxoSmithKline Plc
- Janssen Biotech Inc. (Johnson & Johnson)
- Novo Nordisk A/S
- Pfizer Inc.
- Sanofi SA
- Takeda Pharmaceuticals

簡介目錄圖表

Product Code: SR112023A3069

Abstract

The global gastrointestinal therapeutics market size reached US$ 44.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 59.6 Billion by 2028, exhibiting a growth rate (CAGR) of 5.1% during 2022-2028.

Gastrointestinal (GI) syndrome refers to a medical ailment that affects the functioning of organs in the digestive tract. It impacts the stomach, pancreas, small and large intestines, gall bladder and liver and is usually characterized by indigestion, heartburn, constipation and bloating. Some of the commonly used GI therapeutics include prescription and over-the-counter (OTC) drugs, such as antacids, laxatives, antidiarrheal agents, antiemetics, antiulcer agents, and endoscopic and radiological procedures and hematological tests. These therapeutics assist in the detection of the disorder and absorbing nutrients from the food to improve digestion, regulate water flow in the GI system and minimize gastric acidity.

The increasing prevalence of GI diseases, such as inflammatory bowel disease (IBD) and ulcerative colitis, is one of the key factors driving the growth of the market. Due to changing lifestyle patterns and unhealthy dietary habits, there is an increased probability of disease recurrence among patients across the globe. Furthermore, the rising geriatric population, which is more susceptible to such ailments, is also driving the market growth. Various technological advancements, such as the development of innovative biosimilars and cellular therapies for the treatment of the disorder, are acting as other growth-inducing factors. These biologics are administered through intravenous and subcutaneous injections and are personalized for targeted treatments. Other factors, including rising health consciousness among the masses, extensive research and development (R&D) activities and significant improvements in the healthcare infrastructure, especially in developing economies, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global gastrointestinal therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, route of administration, application and distribution channel.

Breakup by Type:

Branded

Generic

Breakup by Route of Administration:

Oral

Intravenous

Others

Breakup by Application:

Ulcerative Colitis

Crohn's Disease

GERD

Others

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Bausch Health Companies Inc., Bayer Aktiengesellschaft, GlaxoSmithKline Plc, Janssen Biotech Inc. (Johnson & Johnson), Novo Nordisk A/S, Pfizer Inc., Sanofi S.A. and Takeda Pharmaceuticals.

Key Questions Answered in This Report:

How has the global gastrointestinal therapeutics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global gastrointestinal therapeutics market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the application?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global gastrointestinal therapeutics market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Gastrointestinal Therapeutics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Branded
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Generic
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Route of Administration

7.1 Oral
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Intravenous
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Others
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by Application

8.1 Ulcerative Colitis
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Crohn's Disease
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 GERD
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast

9 Market Breakup by Distribution Channel

9.1 Hospital Pharmacies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Retail Pharmacies
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Online Pharmacies
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 AbbVie Inc.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 AstraZeneca Plc
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 Bausch Health Companies Inc.
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Bayer Aktiengesellschaft
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
  - 15.3.5.4 SWOT Analysis
- 15.3.6 GlaxoSmithKline Plc
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
  - 15.3.6.4 SWOT Analysis
- 15.3.7 Janssen Biotech Inc. (Johnson & Johnson)
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
- 15.3.8 Novo Nordisk A/S
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Pfizer Inc.
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Sanofi S.A.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis
- 15.3.11 Takeda Pharmaceuticals
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio
  - 15.3.11.3 Financials
  - 15.3.11.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Gastrointestinal Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Gastrointestinal Therapeutics Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Gastrointestinal Therapeutics Market: Breakup by Type (in %), 2022
Figure 5: Global: Gastrointestinal Therapeutics Market: Breakup by Route of Administration (in %), 2022
Figure 6: Global: Gastrointestinal Therapeutics Market: Breakup by Application (in %), 2022
Figure 7: Global: Gastrointestinal Therapeutics Market: Breakup by Distribution Channel (in %), 2022
Figure 8: Global: Gastrointestinal Therapeutics Market: Breakup by Region (in %), 2022
Figure 9: Global: Gastrointestinal Therapeutics (Branded) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Gastrointestinal Therapeutics (Branded) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Gastrointestinal Therapeutics (Generic) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Gastrointestinal Therapeutics (Generic) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Gastrointestinal Therapeutics (Oral) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Gastrointestinal Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Gastrointestinal Therapeutics (Intravenous) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Gastrointestinal Therapeutics (Intravenous) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Gastrointestinal Therapeutics (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Gastrointestinal Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Gastrointestinal Therapeutics (Ulcerative Colitis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Gastrointestinal Therapeutics (Ulcerative Colitis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Gastrointestinal Therapeutics (Crohn's Disease) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Gastrointestinal Therapeutics (Crohn's Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Gastrointestinal Therapeutics (GERD) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Gastrointestinal Therapeutics (GERD) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Gastrointestinal Therapeutics (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Gastrointestinal Therapeutics (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Gastrointestinal Therapeutics (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Gastrointestinal Therapeutics (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Gastrointestinal Therapeutics (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Gastrointestinal Therapeutics (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Gastrointestinal Therapeutics (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Gastrointestinal Therapeutics (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: North America: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: United States: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: United States: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Canada: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Canada: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: North America: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Asia-Pacific: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: China: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: China: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Japan: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Japan: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: India: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: India: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: South Korea: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: South Korea: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Australia: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Australia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Indonesia: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Indonesia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Asia-Pacific: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Europe: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Germany: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Germany: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: France: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: France: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: United Kingdom: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: United Kingdom: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Italy: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Italy: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Spain: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Spain: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Russia: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Russia: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Europe: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Latin America: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Brazil: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Brazil: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Mexico: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Mexico: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Others: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Others: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: Latin America: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Middle East and Africa: Gastrointestinal Therapeutics Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Middle East and Africa: Gastrointestinal Therapeutics Market: Breakup by Country (in %), 2022
Figure 81: Middle East and Africa: Gastrointestinal Therapeutics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Global: Gastrointestinal Therapeutics Industry: SWOT Analysis
Figure 83: Global: Gastrointestinal Therapeutics Industry: Value Chain Analysis
Figure 84: Global: Gastrointestinal Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Gastrointestinal Therapeutics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
Table 4: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 6: Global: Gastrointestinal Therapeutics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Gastrointestinal Therapeutics Market: Competitive Structure
Table 8: Global: Gastrointestinal Therapeutics Market: Key Players

02-2729-4219

+886-2-2729-4219